Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Infect Dis ; 16: 422, 2016 08 17.
Artigo em Inglês | MEDLINE | ID: mdl-27530444

RESUMO

BACKGROUND: As has occurred in many regions worldwide, in 2012 the incidence of pertussis increased in Perú. This epidemiologic situation has been associated with a waning vaccine-induced immunity and the adaptation of Bordetella pertussis to vaccine-induced immunity along with improved diagnostic methods. METHODS: The study comprised a total of 840 pertussis-suspected cases reported in Perú during 2012. We summarize here the distribution of pertussis cases according to age and immunization status along with the immunization-coverage rate. Laboratory diagnosis was performed by culture test and real-time polymerase-chain reaction (PCR). B. pertussis bacteria recovered from infected patients were characterized by pulsed-field gel electrophoresis (PFGE), and the DNA sequencing of the pertussis-toxin (promoter and subunit A), pertactin, and fimbriae (fim2 and fim3) genes. RESULTS: From the total pertussis-suspected cases, 191 (22.7 %) infections were confirmed by real-time PCR and 18 through cultivation of B. pertussis (2.1 %), while one infection of B. parapertussis (0.11 %) was also detected by culture. Pertussis was significantly higher in patients that had had 0-3 vaccine doses (pentavalent vaccine alone) than in those who had had 4-5 vaccine doses (pentavalent plus DwPT boosters) at 94.3 vs. 5.7 %, respectively (p < 0.00001). The relative risk (RR) for patients with 4-5 doses compared to those with fewer than 4 doses or no dose was 0.23 (95 % Confidence Interval: 0.11-0.44), while the vaccine effectiveness was 77 % and coverage 50.5 %. Genetic analysis of B. pertussis isolates from different Peruvian regions detected two clonal groups as identified by PFGE. Those two groups corresponded to the B. pertussis genotypes emerging worldwide ptxP3-ptxA1-prn2 or 9-fim3-1 and ptxP3-ptxA1-prn2 or 9-fim3-2. CONCLUSIONS: Two emerging B. pertussis genotypes similar to isolates involved in worldwide epidemics were detected in Perú. Low vaccine coverage (<50 %) and genetic divergence between the vaccine-producing strain and the local isolates could contribute to this pertussal epidemic.


Assuntos
Bordetella pertussis/genética , Coqueluche/epidemiologia , Coqueluche/microbiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Proteínas da Membrana Bacteriana Externa/genética , Bordetella pertussis/isolamento & purificação , Bordetella pertussis/patogenicidade , Criança , Pré-Escolar , Surtos de Doenças , Eletroforese em Gel de Campo Pulsado , Feminino , Genótipo , Humanos , Imunização/estatística & dados numéricos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Toxina Pertussis/genética , Vacina contra Coqueluche/administração & dosagem , Peru/epidemiologia , Reação em Cadeia da Polimerase em Tempo Real , Vacinação/estatística & dados numéricos , Fatores de Virulência de Bordetella/genética , Coqueluche/imunologia , Adulto Jovem
2.
Genome Announc ; 1(1)2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23469360

RESUMO

The plague is a zoonotic disease caused by the bacterium Yersinia pestis. Here, we report the complete genome sequence of the Y. pestis strain INS, which was isolated from swollen lymph gland aspirate (bubo aspirate) of an infected patient from a pneumonic outbreak in 2010 in northern Peru.

3.
Genome Announc ; 1(1)2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23409255

RESUMO

Bartonella bacilliformis is the etiological agent of human bartonellosis, which is highly endemic to Peru. Here, we report the first genome that was sequenced and analyzed from an isolate of B. bacilliformis strain INS, which originally was isolated from the blood of an infected patient with an acute phase of Carrion's disease from Jaén-Cajamarca, Peru.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...